Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513097 · ClinicalTrials.gov registry record · Phase 1
Curbing Tobacco Use in Suburban and Rural Schools
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 1,289
- Enrollment target
NCT00513097: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT00513097 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,289 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (2048% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00513097, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1,289 participants
- Enrollment target
Study Summary
Primary, secondary, and tertiary specific aims are to answer the following questions about interactive, Internet-based tobacco control intervention directed towards 10th-graders: 1. Smoking Prevention (primary): Does the intervention result in a lower incidence of smoking initiation compared to standard care? 2. Smoking Cessation (primary): Does the intervention result in higher rates of smoking cessation compared to standard care? 3. Reduction of Spit Tobacco Use (secondary): Does the intervention have an impact on spit tobacco use compared to standard care? 4. Stages of Change (tertiary): Does the intervention have an impact on progression through the stages of smoking and spit tobacco acquisition and cessation compared to standard care? 5. Mediating Variables (tertiary): How are mediating variables associated with tobacco-use onset and cessation? 6. Testing Predictors: Investigate established and recently elucidated predictors of susceptibility to smoking at baseline and 12-month follow-up. 7. Develop/Validate Spit Tobacco Measures: Investigate predictors of susceptibility of spit tobacco use at baseline and 12-month follow-up 8. Testing Measures Across Race/Ethnicity: Explore predictors of susceptibility to smoking at baseline and 12-month follow-up to determine whether predictors differ among White, African-American, and Hispanic students.
Interventions
- BEHAVIORAL Focus Group
- BEHAVIORAL Survey
- BEHAVIORAL Smoking Prevention Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,289 participants |
| Start Date | 2006-07-25 |
| Est. Completion | 2017-10-18 |
| Phase | Phase 1 |
What the finished NCT00513097 record still lists
NCT00513097 is an interventional study that assigns participants to a tested intervention. Its 1,289 participants enrollment target places it among the larger protocols in the corpus, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (2048% higher).
The record links to 0 conditions, and to 3 interventions - of which Focus Group is the first listed.
NCT00513097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00513097 about?
NCT00513097 is a clinical study titled "Curbing Tobacco Use in Suburban and Rural Schools". Primary, secondary, and tertiary specific aims are to answer the following questions about interactive, Internet-based tobacco control intervention directed towards 10th-graders: 1. Smoking Prevention (primary): Does the intervention result in a lower incidence of smoking initiation compared to sta...
What is the current status of trial NCT00513097?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1,289 participants. The study started on 2006-07-25. Estimated completion is 2017-10-18.
What interventions are being tested in trial NCT00513097?
The interventions under investigation include: Focus Group (BEHAVIORAL), Survey (BEHAVIORAL), Smoking Prevention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00513097?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00513097's enrollment target sits among peer trials
1,289 5th of 2000 higher than 1,996 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI